Clinical Trials in Austin

Showing 7441-7460 of 11,561 trials

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

This study was designed to conduct a comparative trial to further evaluate the safety, immunogenicity and antibody persistence of two doses of Novartis MenACWY conjugate vaccine, given 2 months apart, versus one dose of Novartis MenACWY conjugate vaccine in children 2 through 10 years of age.

Meningococcal DiseaseInfections, Meningococcal

GlaxoSmithKline715 participantsStarted Oct 2012

Birmingham, Alabama, United States • Sacramento, California, United States • Lake Mary, Florida, United States +16 more locations

COMPLETEDPhase 3< 1 mile

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Irritable Bowel Syndrome Characterized by Constipation

Bausch Health Americas, Inc.1,054 participantsStarted Dec 2014

Athens, Alabama, United States • Birmingham, Alabama, United States • Dothan, Alabama, United States +152 more locations

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Find Trials by Condition in Austin

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Genetic Assessment of Early to Late Macular Degeneration Study

Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age